PALATIN TECHNOLOGIES INC (PTN) research
PALATIN TECHNOLOGIES INC- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $9.33
- As of
PALATIN TECHNOLOGIES INC (PTN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-K filed 2026-09-28.
As of . Source: SEC EDGAR filings for PTN. Method and limitations.
Share the PTN intelligence card
See the full PTN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PTN on one page. Preview it with sample data, then open it live with a free account.
Preview the PTN dossierActive signals for PTN
- mediumEARNINGS_BEAT
Q4-2026: Beat consensus by 8.4%, EPS $-1.11 vs $-1.212 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 71.7% - EPS $-6 vs $-21.21 estimate
- mediumEARNINGS_BEAT
Beat consensus by 71.7% - EPS $-6 vs $-21.21 estimate
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 20.3% - EPS $-2.86 vs $-2.3769 estimate
- mediumEARNINGS_BEAT
Q3-2026: Beat consensus by 70.5% - EPS $-0.37 vs $-1.2558 estimate
FREE, NO ACCOUNT
Every signal on PTN, as it fires
New filings, 13F moves and cross asset signals on PTN land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, PTN
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PTN against its peers
PTN's operating margin of -65.7% ranks in the 88th percentile of 11 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | PTN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 13.2M USD | 1.2M USD | 88 | 12 |
| Operating margin | -65.7% | -986.6% | 88 | 11 |
| Net margin | -63.5% | -984.6% | 96 | 11 |
| Return on equity | -125.3% | -112.5% | 31 | 20 |
Peers (23): NCEL, LPCN, CLRB, INTI, ACTU, TVRD, LSTA, KTTA, KPTI, BCDA, CYCN, SNSE, DYAI, MRKR, ESLA, ALLR, VYNE, AKTX, PASG, ICU, ATOS, DARE, NEUP. Left out: FNCHQ (period gap), CTXR (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PTN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PTN signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PTNand get the insider, 13F, options, and confluence read in one view.